1. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
- Author
-
Triguero, Ana, Pedraza, Alexandra, Pérez-Encinas, Manuel, Mata-Vázquez, María Isabel, Vélez, Patricia, Fox, Laura, Gómez-Calafat, Montse, García-Delgado, Regina, Gasior, Mercedes, Ferrer-Marín, Francisca, García-Gutiérrez, Valentín, Angona, Anna, Gómez-Casares, María Teresa, Cuevas, Beatriz, Martínez, Clara, Pérez, Raúl, Raya, José María, Guerrero, Lucía, Murillo, Ilda, Bellosillo, Beatriz, Hernández-Boluda, Juan Carlos, Sanz, Cristina, Álvarez-Larrán, Alberto, On behalf of the MPN Spanish Group (GEMFIN), Institut Català de la Salut, [Triguero A, Pedraza A] Hospital Clinic de Barcelona, Barcelona, Spain. [Pérez-Encinas M] Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain. [Mata-Vázquez MI] Hospital Costa del Sol, Marbella, Spain. [Vélez P] Hospital del Mar, Barcelona, Spain. [Fox L] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Neoplasms::Neoplasms by Site::Hematologic Neoplasms::Bone Marrow Neoplasms::Polycythemia Vera [DISEASES] ,Correction ,Myelofibrosis ,Otros calificadores::Otros calificadores::/cirugía [Otros calificadores] ,Thrombosis ,Hematology ,General Medicine ,Middle Aged ,Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores] ,Polycythemia vera ,Phlebotomies ,Other subheadings::Other subheadings::/surgery [Other subheadings] ,Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Specimen Handling::Blood Specimen Collection::Phlebotomy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,Low-risk ,diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::manejo de muestras::extracción de muestras sanguíneas::flebotomía [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Leukemia, Myeloid, Acute ,Phlebotomy ,Policitèmia - Cirurgia ,Sagnia - Complicacions ,Primary Myelofibrosis ,neoplasias::neoplasias por localización::neoplasias hematológicas::neoplasias de la médula ósea::policitemia vera [ENFERMEDADES] ,Other subheadings::Other subheadings::/adverse effects [Other subheadings] ,Humans ,Registries ,Polycythemia Vera - Abstract
Myelofibrosis; Phlebotomies; Thrombosis Mielofibrosi; Flebotomies; Trombosi Mielofibrosis; Flebotomías; Trombosis Hematological control, incidence of complications, and need for cytoreduction were studied in 453 patients with low-risk polycythemia vera (PV) treated with phlebotomies alone. Median hematocrit value decreased from 54% at diagnosis to 45% at 12 months, and adequate hematocrit control over time ( 60 years, and microvascular symptoms constituted the main indications for starting cytoreduction. Median duration without initiating cytoreduction was significantly longer in patients younger than 50 years (
- Published
- 2022